Thomas Nguyen, MD

• Department of Emergency Medicine
• Beth Israel Medical Center, Albert Einstein College of Medicine
• New York, New York

Have you crossed a diagnostic threshold for the leading hypothesis varicella zoster Alternative Diagnosis: Bullous Impetigo Textbook Presentation Most commonly seen in children arrhythmia test questions cheap nifedipine 20 mg buy, bullous impetigo presents as flaccid blood pressure chart sleeping nifedipine 20 mg order mastercard, transparent bullae in the intertriginous areas heart attack high head shot hotel feat jon johnson purchase nifedipine 20 mg without prescription. Superficial skin infection that most commonly affects infants and young children D blood pressure below normal nifedipine 20 mg purchase otc. Oral antibiotics active against S aureus should be prescribed for bullous impetigo blood pressure medication vision problems discount nifedipine 30 mg. Localized, nonbullous impetigo may be adequately treated with topical antibiotics (effective against gram-positive cocci) such as: 1. Eradication measures including daily washing with chlorhexidine gluconate, intranasal mupirocin ointment, and oral rifampin and doxycycline have been modestly successful. Family members and close contacts may also be colonized and warrant investigation and treatment when appropriate. Environmental sources such as shared towels, athletic equipment and such should be considered. Alternative Diagnosis: Bullous Arthropod Bites Textbook Presentation this condition commonly presents as a cluster of tense blisters on exposed skin. The lesions tend to develop in exposed areas of the skin, such as the extremities. Although the blisters arise from otherwise normal skin, surrounding inflammatory changes from rubbing and scratching are often present. Arthropod bite reactions are dermal hypersensitivity reactions to antigens in the saliva of insects. Because bedbugs (as well as fleas) are a common culprit, this diagnosis has recently become more common. Histopathology, though rarely necessary, can be supportive, demonstrating edema, a subepidermal blister, and a dermal inflammatory infiltrate with numerous eosinophils. Attention to eradicating the source of the biting insects, such as on pets, nests, etc. Alternative Diagnosis: Bullous Pemphigoid Textbook Presentation Bullous pemphigoid is usually seen in elderly patients with the sudden onset of 1­2 cm tense blisters and bright red, urticarial plaques. Autoantibodies are targeted against components of the epidermal basement membrane zone, thus triggering separation and blistering. These distinct antibodies cause other blistering syndromes, such as pemphigus vulgaris and epidermolysis bullosa acquisita. Histopathology provides supportive information, demonstrating a subepidermal blister plane and accumulation of eosinophils. Immunopathology confirms the diagnosis by demonstrating linear deposits of IgG and C3 at the dermal­epidermal junction. In 70­80% of patients, circulating IgG that recognizes the identified antigens of the basement membrane zone can be found. Steroid-sparing immunosuppressives are used to limit the toxicities of systemic corticosteroids in chronic disease. Alternative antiinflammatory regimens such as tetracycline and nicotinamide may be effective. Remission is usually obtained within a few weeks; however, some degree of long-term therapy may be necessary. Alternative Diagnosis: Stevens-Johnson Syndrome Textbook Presentation Stevens-Johnson syndrome typically presents in a patient with fever, malaise, headache, and myalgias who is taking a potentially causative medication. Description of the lesion: flaccid bullae and vesicles that develop centrally within preexisting target lesion. Stevens-Johnson syndrome and toxic epidermal necrolysis are hypersensitivity reaction patterns involving the skin. Stevens-Johnson syndrome involves less body surface area, whereas toxic epidermal necrolysis leads to considerable areas of full-thickness skin sloughing. More than 200 drugs have been implicated as causes of Stevens-Johnson syndrome and toxic epidermal necrolysis. Medications most commonly implicated in Stevens-Johnson syndrome or toxic epidermal necrolysis. The rash occurs initially on the face and central trunk as pink to red macules and papules. The rash may spread and evolve rapidly, with individual lesions becoming targetoid with dusky centers and ultimately coalescing into larger plaques. Flaccid bullae and vesicles may develop centrally within targets as the skin necroses. Blisters form and rapidly erode, leaving red and raw skin that becomes coated by a gray-white pseudomembrane. A hallmark of Stevens-Johnson syndrome and toxic epidermal necrolysis is the presence of exquisite skin tenderness. Pathology demonstrates epidermal necrosis with minimal evidence of epidermal and dermal inflammation. Some studies support the use of intravenous immunoglobulin in the early stages of the disease to abort progression. He was instructed to keep the skin lesions covered to prevent contacts from being exposed to the infective vesicle fluid. He was counseled to avoid close contact with young infants and immunosuppressed individuals until all skin lesions are crusted. On examination, there are many 1­2 cm discrete, brightly erythematous plaques and papules with adherent white scale. Some lesions appear somewhat linear in configuration, whereas most are round to oval in shape. Common causes of papulosquamous eruptions are psoriasis, pityriasis rosea, fungal infections, and nummular dermatitis. In addition, the finding of pharyngeal injection suggests that there may be an infectious component (as is common with guttate psoriasis). The configuration of the lesions and the scale can be very helpful in narrowing the differential diagnosis. Tinea infections typically have scale at the border of the lesions (leading edge with advancing scale) and pityriasis rosea has scale at the center of the lesion (trailing scale). Nummular dermatitis is usually found on the extremities and is associated with significant pruritus, making it an unlikely diagnosis in this case. Syphilis can present with plaques, but they often involve the palms and soles and lack an adherent scale (Table 29-4). Leading Hypothesis: Guttate Psoriasis Textbook Presentation Guttate psoriasis generally presents with small, round, and slightly oval lesions on the back and trunk. The lesions may localize to sites of minor skin trauma, such as scrapes (Koebner phenomenon). Most commonly seen in young adults, frequently preceded by a streptococcal throat infection. Affected patients are at increased risk for development of psoriasis vulgaris in the next 3­5 years. A skin biopsy of an established lesion may demonstrate classic histologic findings of psoriasis vulgaris. Guttate psoriasis is typically a self-limited eruption, although clearance can take weeks to months. Antibiotics with antiinflammatory properties, such as erythromycin and tetracycline, can be additionally helpful for flares. Appropriate antibiotic treatment of any potentially causative infection should be administered. Systemic corticosteroids should be avoided in psoriasis because withdrawal may trigger flares. Have you crossed a diagnostic threshold for the leading hypothesis, guttate psoriasis Alternative Diagnosis: Pityriasis Rosea Textbook Presentation Pityriasis rosea commonly presents as a "herald patch" and then multiple small, oval, scaly plaques develop over the trunk. The primary eruption appears as a single oval or round, pink to brownish plaque with a collarette of scale around the inner margin of the lesion (the herald patch). This herald patch most often occurs on the trunk and is often misdiagnosed as tinea corporis. One to 2 weeks after the appearance of the herald patch, the secondary eruption emerges as generalized smaller but similar oval scaly plaques distributed along skin tension lines in a "fir tree" pattern. Spontaneous resolution occurs over 8­12 weeks, often with subsequent postinflammatory hypopigmentation or hyperpigmentation. A history of a mild prodrome of malaise, nausea, headache, and low-grade fever may be present. Pityriasis rosea is a common worldwide disease without genetic or racial predilection, occurring sporadically throughout the year. A viral cause is postulated; evidence suggests but does not confirm a role for human herpesvirus 7. The diagnosis is clinical, based on morphology and distribution of the skin lesions. Skin biopsy demonstrates many nonspecific findings of a subacute dermatitis but can provide supportive evidence for the diagnosis. No specific treatment is indicated or effective; the condition resolves over 8­12 weeks. In cases with severe pruritus, symptomatic treatments, such as antihistamines and mild topical corticosteroids, may be beneficial. Alternative Diagnosis: Tinea Corporis Textbook Presentation Tinea corporis commonly presents as round, pink plaques with small peripheral papules and a rim of scales. Circular lesions with a sharply marginated raised border and central clearing, arising by centrifugal spread of the fungus from the initial site of infection 2. Inflammatory lesions may demonstrate pustules or vesicles, especially around the margin. Solitary lesions may occur, or there may be multiple plaques that remain discrete or become confluent. The degree of associated inflammatory change is variable, depending on the causative species of fungus. The wide variation in clinical presentation depends on the species of fungus, size of the inoculum, body site infected, and immune status of the patient. Identification of the fungus by microscopic examination of scales after application of 5­20% potassium hydroxide B. Histopathology is rarely necessary to make the diagnosis of a superficial infection, but with the use of fungal stains the cell walls may be visible in fixed sections. Description of lesions: well-demarcated coin-shaped lesions composed of minute vesicles and papules on an erythematous base. Nummular dermatitis is an acute eruption of numerous lesions predominantly on the extremities. Histopathology can assist in the diagnosis by demonstrating the features of an acute dermatitis. If present, secondary infections often require treatment with systemic antibiotics. Skin care, especially bathing practices and appropriate use of emollients, should be stressed. Alternative Diagnosis: Secondary Syphilis Textbook Presentation Secondary syphilis presents as oval macules in sexually active people. A history of a transient, painless, genital ulcer in the preceding weeks can often be obtained. A fleeting eruption of symmetric, coppery red, round and oval macules may be seen early in the secondary stage, about 8 weeks after the infecting exposure. The later, classic eruption includes involvement of mucosal surfaces and palms and soles. The patient was prescribed 10 days of penicillin as well as topical corticosteroids and topical calcipotriene. The guttate flares tend to remit quite reliably; however, affected individuals are at increased risk for the development of chronic psoriasis. Description of the lesion: transient pink to red gently elevated edematous papules and plaques that may coalesce into giant lesions. Individual lesions should resolve within 24 hours while new lesions may continue to develop. Mucous membranes, eyelids, hands, and feet may develop deeper subcutaneous swelling manifesting as angioedema. Idiopathic should probably be added to this list because the etiologic agent may induce an immunologic cascade that persists in the absence of the inciting agent. Chronic urticaria (lasting > 6 weeks) can also be seen in the setting of systemic disease such as collagen vascular disease, malignancy, parasitosis, and chronic infection. Clinical findings of typical transient urticaria are diagnostic, and a skin biopsy is rarely indicated. Urticaria can be distinguished from all of the above disorders because it is the only one with lesions that last > 24 hours. A careful history, including review of medications, recent exposures, and food ingestion, is the most important aspect of the evaluation to determine a cause. Laboratory evaluation is sometimes undertaken in cases of chronic urticaria, but studies have shown that relevant results are so rarely found without other symptoms that this approach is discouraged. Identification of the inciting agent (medication, supplement, infection) is paramount and should be addressed as the first step in management. H1-blockers should be given on a regular dosing schedule until the eruption is suppressed and then tapered gradually to prevent rebound flare. Combinations of different H1-blockers can be effective when a single agent is inadequate. Purpura/Petechiae Textbook Presentation Purpura and petechiae are seen in patients with bleeding diatheses or vascular damage. Petechiae are capillary hemorrhages that present as nonblanching, pinpoint, red spots over dependent body parts, most commonly the lower extremities. Purpura are associated with a variety of life-threatening diseases such as vasculitis and sepsis. Description of the lesion: petechiae are red, blue or purple, nonblanching, pinpoint spots.

Visualization of structures is not ideal because of the low intensity of the signal emission blood pressure medication and exercise buy discount nifedipine line. Direct immunofluorescence methods are now being replaced by the indirect method because of suboptimal sensitivity pulse pressure in neonates order nifedipine with mastercard. Indirect immunofluorescence provides much greater sensitivity than direct methods and is often referred to as the "sandwich" or "double-layer technique blood pressure medication while breastfeeding buy nifedipine 20 mg fast delivery. Therefore arteria jugularis externa buy nifedipine paypal, when the fluorescein is conjugated directly with the specific primary antibody arrhythmia breathing cheap nifedipine 30 mg line, the method is direct; when fluorescein is conjugated with a secondary antibody, the method is indirect. The indirect method considerably enhances the fluorescence signal emission from the tissue. An additional advantage of the indirect labeling method is that a single secondary antibody can be used to localize the tissue-specific binding of several different primary antibodies. For microscopic studies, the secondary antibody can be conjugated with different fluorescent dyes so that multiple labels can be shown in the same tissue section. Drawbacks of indirect immunofluorescence are that it is expensive, labor intensive, and not easily adapted to automated procedures. It is also possible to conjugate polyclonal or monoclonal antibodies with other substances, such as enzymes. The staining that results from this immunoperoxidase method can be observed in the light microscope. In another variation, colloidal gold or ferritin (an iron-containing molecule) can be attached to the antibody molecule. These electron-dense markers can be visualized directly with the electron microscope. In direct immunofluorescence, a fluorochrome-labeled primary antibody reacts with a specific antigen within the tissue sample. Labeled structures are then observed in the fluorescence microscope in which an excitation wavelength (usually ultraviolet light) triggers the emission of another wavelength. The length of this wavelength depends on the nature of the fluorochrome used for antibody labeling. Second, the secondary antibodies, which are fluorochrome labeled, react with the primary antibodies. The visualization of labeled structures within the tissue is the same in both methods and requires the fluorescence microscope. The behavior of microtubules (elements of the cell cytoskeleton) obtained from human breast tumor cells can be studied in vitro by measuring their nucleation activity, which is initiated by the centrosome. By use of indirect immunofluorescence techniques, microtubules were labeled with a mixture of anti­ -tubulin and anti­ -tubulin monoclonal antibodies (primary antibodies) and visualized by secondary antibodies conjugated with fluorescein dye (fluorescein isothiocyanate­goat anti-mouse immunoglobulin G). The antigen­antibody reaction, performed directly on the glass coverslip, results in visualization of tubulin molecules responsible for the formation of more than 120 microtubules visible on this image. They originate from the centriole and extend outward approximately 20 to 25 m in a uniform radial array. The amplified transcripts obtained during these procedures are usually detected using labeled complementary nucleotide probes in standard in situ hybridization techniques. Recently, fluorescent dyes have been combined with nucleotide probes, making it possible to visualize multiple probes at the same time. For example, a probe hybridized to metaphase chromosomes can be used to identify the chromosomal position of a gene. The frequency of chromosome translocations in lymphocytes is proportional to the absorbed radiation dose. Autoradiography Autoradiography makes use of a photographic emulsion placed over a tissue section to localize radioactive material within tissues. Hybrids are detected most often using a radioactive label attached to one component of the hybrid. Binding of the probe and sequence can take place in a solution or on a nitrocellulose membrane. Digoxigenin and biotin are detected by immunocytochemical and cytochemical methods, respectively. The right nucleus is from a normal amniotic fluid specimen and exhibits two green and two orange signals, which indicates two copies of chromosomes 13 and 21, respectively. The nucleus on the left has three orange signals, which indicate trisomy 21 (Down syndrome). The radioactivity is then traced to localize the larger molecules in cells and tissues. Labeled precursor molecules can be injected into animals or introduced into cell or organ cultures. Sections of specimens that have incorporated radioactive material are mounted on slides. In the dark, the slide is usually dipped in a melted photographic emulsion, thus producing a thin photographic film on the surface of the slide. After appropriate exposure in a light-tight box, usually for days to weeks, the exposed emulsion on the slide is developed by standard photographic techniques and permanently mounted with a coverslip. The silver grains in the emulsion over the radioactively labeled molecules are exposed and developed by this procedure and appear as dark grains overlying the site of the radioactive emission when examined with the light microscope. These grains may be used simply to indicate the location of a substance, or they may be counted to provide semiquantitative information about the amount of a given substance in a specific location. Some of the cells exhibit aggregates of metallic silver grains, which appear as small black particles (arrows). Over time, the lowenergy radioactive particles emitted from the [3H]thymidine strike silver halide crystals in a photographic emulsion covering the specimen (exposure) and create a latent image (much like light striking photographic film in a camera). During photographic development of the slide with its covering emulsion, the latent image, actually the activated silver halide in the emulsion, is reduced to the metallic silver, which then appears as black grains in the microscope. Electron microscopic autoradiograph of the apical region of an intestinal absorptive cell. Note that the silver grains are concentrated over apical invaginations (inv) and early endosomal tubular profiles (tub). A specimen to be examined with the bright-field microscope must be sufficiently thin for light to pass through it. Although some light is absorbed while passing through the specimen, the optical system of the bright-field microscope does not produce a useful level of contrast in the unstained specimen. The resolving power of the human eye-that is, the distance by which two objects must be separated to be seen as two objects (0. The role of a microscope is to magnify an image to a level at which the retina can resolve the information that would otherwise be below its limit of resolution. Examination of a Histologic Slide Preparation in the Light Microscope Organs are three-dimensional, whereas histologic sections are only two-dimensional. This is the theoretical resolution and, as mentioned, depends on all conditions being optimal. The ocular or eyepiece lens magnifies the image produced by the objective lens, but it cannot increase resolution. Various light microscopes are available for general and specialized use in modern biologic research. Their differences are based largely on such factors as the wavelength of specimen illumination, physical alteration of the light coming to or leaving the specimen, and specific analytic processes that can be applied to the final image. The microscope used by most students and researchers is the bright-field microscope. As discussed in the earlier "Tissue Preparation" section, every tissue sample prepared for light microscopic examination must be sliced into thin sections. Thus, two-dimensional sections are obtained from an original three-dimensional sample of tissue. One of the most challenging aspects for students using the microscope to study histology is the ability to mentally reconstruct the "missing" third dimension. Note that each cut surface (indicated by the dotted line) of the whole orange reveals different sizes and surface patterns, depending on the orientation of the cut. Thus, it is important when observing a given section cut through the orange to be able to mentally reconstruct the organization of the structure and its component parts. An example of a histologic structure-in this case, a kidney renal corpuscle-is shown as it would appear in different sectional planes. By examining a number of such two-dimensional sections, it is possible to create the three-dimensional configuration of the examined structure. Artifacts in histologic slides can be generated in all stages of tissue preparation. The bright-field microscope is the direct descendant of the microscopes that became widely available in the 1800s and opened the first major era of histologic research. During each step, an artifact (an error in the preparation process) may be introduced. In general, artifacts that appear on the finished glass slide are linked to methodology, equipment, or reagents used during preparation. The inferior purity of chemicals and reagents used in the process (fixatives, reagents, and stains), imperfections in the execution of the methodology (too short or too long intervals of fixation, dehydration, embedding, staining, or careless mounting and placement of the coverslip), or improper equipment. It is important for students to recognize that not every slide in their slide collection is perfect and that they should be familiar with the most common artifacts found on their slides. Other Optical Systems Besides bright-field microscopy, which is commonly used for routine examination of histologic slides, other optical systems (described below) are used in clinical and research laboratories. Some of them are used to enhance the contrast without staining (such as phase contrast microscopes), whereas others are designed to visualize structures using specific techniques such as immunofluorescence (fluorescence and confocal microscopes). The phase contrast microscope enables examination of unstained cells and tissues and is especially useful for living cells. Two modifications of the phase contrast microscope are the interference microscope, which also allows quantification of tissue mass, and the differential interference microscope (using Nomarski optics), which is especially useful for assessing surface properties of cells and other biologic objects. In dark-field microscopy, no direct light from the light source is gathered by the objective lens. The phase contrast microscope takes advantage of small differences in the refractive index in different parts of a cell or tissue sample. Light passing through areas of relatively high refractive index (denser areas) is deflected and becomes out of phase with the rest of the beam of light that has passed through the specimen. The phase contrast microscope adds other induced, out-of-phase wavelengths through a series of optical rings in the condenser and objective lenses, essentially abolishing the amplitude of the initially deflected portion of the beam and producing contrast in the image. Dark portions of the image correspond to dense portions of the specimen; light portions of the image correspond to less dense portions of the specimen. The phase contrast microscope is therefore In dark-field microscopy, only light that has been scattered or diffracted by structures in the specimen reaches the objective. The dark-field microscope is equipped with a special condenser that illuminates the specimen with strong, oblique light. Thus, the field of view appears as a dark background on which small particles in the specimen that reflect some light into the objective appear bright. The effect is similar to that of dust particles seen in the light beam emanating from a slide projector in a darkened room. The light reflected off the dust particles reaches the retina of the eye, thus making the particles visible. The resolution of the dark-field microscope cannot be better than that of the bright-field microscope, using, as it does, the same wavelength source. The dotted lines drawn on the intact orange indicate the plane of section that correlates with each cut surface. Similarly, different sections through a kidney renal corpuscle, which is also a spherical structure, show differences in appearance. The size and internal structural appearance are reflected in the plane of section. Methods be detected in dark-field images, however, because of the enhanced contrast that is created. The dark-field microscope is useful in examining autoradiographs, in which the developed silver grains appear white in a dark background. Clinically, dark-field microscopy is useful in examining urine for crystals, such as those of uric acid and oxalate, and in demonstrating specific bacteria such as spirochetes, particularly Treponema pallidum, the microorganism that causes syphilis, a sexually transmitted disease. The fluorescence microscope makes use of the ability of certain molecules to fluoresce under ultraviolet light. Then open the field diaphragm until the light beam covers the full field observed. You will see an illuminated circular field that has a radius directly proportional to the numeric aperture of the objective. As you close the condenser diaphragm, its outline will appear in this circular field. For most stained materials, set the condenser diaphragm to cover approximately two-thirds of the objective aperture. This setting results in the best compromise between resolution and contrast (contrast simply being the intensity difference between dark and light areas in the specimen). Using only these five simple steps, the image obtained will be as good as the optics allow. Illuminating a larger field than the optics can "see" only leads to internal reflections or stray light, resulting in more "noise" or a decrease in image contrast. Second, why do we emphasize the setting of the condenser diaphragm-that is, the illuminating aperture This diaphragm greatly influences the resolution and the contrast with which specimen detail can be observed. If the following comments appear elementary, it is only because most users of the microscope fail to use it to its fullest advantage. Expensive and highly corrected optics perform optimally only when the illumination and observation beam paths are centered and properly adjusted. The use of proper settings and proper alignment of the optic pathway will contribute substantially to the recognition of minute details in the specimen and to the faithful display of color for the visual image and for photomicrography.

PancreasTransplantRecipients Transplantation of the liver differs from other transplant operations in the length and difficulty of the surgery and the frequency of bleeding prehypertension in your 20s buy cheapest nifedipine and nifedipine. In addition blood pressure chart high systolic low diastolic 30 mg nifedipine purchase free shipping, many liver transplant recipients have poor nutrition and severe metabolic difficulties arrhythmia nifedipine 30 mg buy cheap. Abdominal infections after liver transplantation are often related to technical aspects and complications of the operation arteria dorsalis nasi discount nifedipine 20 mg on line. Most liver abscesses in the transplanted liver are related to surgical problems such as biliary stricture and hepatic artery thrombosis blood pressure below 60 cheap nifedipine 20 mg on-line. The organisms responsible are gram-negative enteric bacilli, enterococci, and anaerobes. Treatment with drainage and intravenous antibiotics is usually successful, provided the source is biliary infection and any structural abnormalities can be corrected. If hepatic artery thrombosis is the predisposing factor, the infectious symptoms can usually be controlled with antibiotics, but retransplantation may be necessary. Some patients improve after dilatation procedures or stent placement, but in others operative repair is necessary. Small bowel transplantation is unique because the gut harbors not only a large burden of lymphoid tissue but also cells that are the least well tolerated of any organ. Consequently, small bowel transplantation recipients are particularly susceptible to graft-versus-host disease and the managing the risk of rejection, infection, and graft-versus-host disease has proven challenging. Small bowel transplantation is often combined with a liver graft due to concurrent existence of intestinal failure-associated liver disease. Notably, inclusion of liver graft with intestinal graft may be immunologically protective; however, isolated intestinal transplantation is becoming increasingly more frequent, likely due to improved management of intestine failure­associated liver dysfunction. More than 90% of the small bowel transplantation recipients develop significant infections, and the rates of infection are higher than in other transplant groups. Multivisceral transplant recipients and patients undergoing colonic segment transplantation with small bowel transplantation are more likely to develop infections. The susceptibility of small bowel transplant recipients to infections continues in the late post-transplantation period. The inability to discern a source is not rare, especially in liver transplant recipients; up to 21% of the bacteremias in liver transplant recipients have had no documented source, but most of these probably originated in the abdomen. The trend of increasing antimicrobial resistance among gram-negative bloodstream isolates may affect local decisions regarding empirical antibiotic therapy of transplant patients who present with possible bloodstream infections. The usual microbial causes of pneumonia in the transplant recipient are listed in Table 313-4. They are subdivided according to whether the pneumonia occurs during the first month after transplantation or later and whether the cause is common or less common. The key to the management of pulmonary infections in transplant recipients is rapid identification of the responsible pathogen and initiation of specific therapy. Patients with a brief duration of symptoms (3 days) who have a focal chest infiltrate and are producing sputum with neutrophils on Gram stain are likely to have a routine bacterial pneumonia. Empirical therapy to cover common typical and atypical bacterial pathogens can be initiated while culture results are awaited. Patients who have an illness lasting longer than 7 days and who have a nonproductive cough or diffuse infiltrates or nodular lesions on chest imaging are more likely to have an unusual or opportunistic pathogen, and consideration should be given to timely use of invasive diagnostic procedures, including bronchoscopy, to establish the diagnosis. Nodular infiltrates have a broad range of infectious etiologies (Table 313-5), and certain clinical and radiographic features may be helpful in discerning a specific etiology. The frequency of Legionella infection varies widely, depending on its endemicity in the hospital and the sensitivity of diagnostic methods. The radiographic presentation is variable and may include focal infiltrates, nodular pleural-based lesions, lung abscess, and pleural or pericardial effusion. Legionellosis in transplant patients should be treated with a quinolone antibiotic or azithromycin. Infections caused by Aspergillus, Nocardia, or endemic mycoses may be relatively common in some regions. Rarely, mucormycosis can cause a surgical site infection in a transplant recipient. Subcutaneous infections caused by Alternaria, Exophiala, and other darkly pigmented or dematiaceous fungi are encountered occasionally. Unlike stem cell transplant recipients, organ transplant recipients rarely develop fusariosis. As a rule, one should aggressively investigate any new or unusual skin lesion with a biopsy. InfectionsoftheUrinaryTract Urinary tract infections are discussed earlier (see "Kidney Transplant Recipients"). Bacteremia occurs in 5% to 10% of the kidney and heart transplant recipients with higher rates (10% to 25%) in liver and lung transplant recipients (see Table 313-2). Besides catheter-related infections, pneumonia in heart and heart-lung transplant recipients, urinary tract infections and perinephric sources in renal transplant recipients, abdominal and biliary infections in liver transplant recipients, and surgical site and urinary tract infections in pancreatic transplant recipients are the most commonly identifiable sources of bacteremia. The highest incidence of gram-negative bloodstream infections has been observed within the first month after transplantation (210. Among organ transplant recipients, lung recipients have the highest incidence and attack rate. The basic approach to bacteremia is the same whether or not the patient has undergone transplantation and it includes ascertaining the source of the bacteremia and likely pathogen. Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients. Mycobacterium tuberculosis is a major pulmonary pathogen, particularly in geographic areas where tuberculosis is endemic. Interferon therapy is not recommended in patients with decompensated cirrhosis because it may worsen the liver disease and is poorly tolerated. These cases are marked by a high viral load, and liver biopsies show severe hepatocyte dropout with minimal parenchymal inflammation. Excess deaths are due to not only the direct effects of liver disease but also a higher rate of sepsis. In actual practice, interferon and ribavirin have side effects that make them difficult to administer to liver transplant recipients, so only a small proportion of the patients are actually able to benefit from their use. Currently, treatment is generally used only in patients with histologically significant disease (grade 3 or 4 inflammation, grade 2 to 4 fibrosis) rather than preemptively in all infected patients. These infections also occur with an increased frequency among recipients of pancreas and small bowel transplants. When they do occur, they are usually related to preexisting medical conditions, such as biliary stones or diverticulosis. Studies in developing countries show that transplant recipients are susceptible to Salmonella infection, but infections caused by Shigella or Campylobacter do not appear to be increased in frequency. Most of these tumors have regressed after reduction of immunosuppression and use of antibiotics to treat the Helicobacter infection. Hyperinfection and disseminated infection with Strongyloides were substantial problems in the past but appear to be uncommon. Universal pretransplantation screening for Strongyloides is probably not cost-effective, but vigilance for this infection should be maintained for patients from endemic areas. In the 1980s, 5-year survival rate after transplantation for such patients was approximately 50%. A paucity of inflammatory response in this syndrome suggests that the virus may be directly cytopathic. In the past, many transplant centers considered chronic hepatitis B infection to be a contraindication to liver transplantation. Agents of mucormycosis Dematiaceous fungi Other Pathogens Toxoplasma gondii However, important drug interactions with current immunosuppressants will be a major challenge with the use of these agents in transplant patients. However, progression to chronic hepatitis may occur in organ transplant recipients. Listeria monocytogenes typically causes bacteremia, meningitis, and, at times, cerebritis in transplant recipients. The most common portal of entry is the lung; invasive sinus infection also occurs but is less common. Patients with aspergillosis typically have risk factors such as renal dysfunction or are requiring augmented immunosuppression. The type of transplant is also important: lung and liver transplant recipients are more susceptible than other transplant patients. Aspergillus is an angiotropic mold, and hematogenous spread to the brain can occur early in the course of the infection. Other fungi that may cause parenchymal brain infections in transplant recipients include Mucorales and dematiaceous fungi such as Cladophialophora. Cryptococcal meningitis usually occurs in the late posttransplantation period and has a subacute course. Pulmonary disease caused by Cryptococcus coexists in about 40%, and fungemia is present in 33% to 35% of the cases. The spinal fluid usually has fewer than 500 white blood cells/mL with lymphocytic predominance and a positive cryptococcal antigen test. Overall mortality in solid-organ transplant recipients with cryptococcosis is approximately 15% to 20%. Receipt of calcineurin inhibitors is associated with a lower mortality rate that may be attributable in part to the synergistic interactions of calcineurin inhibitors with antifungal azoles. Toxoplasma infection has been reported in all types of solid-organ transplantation but has most often been described in cardiac transplantation, because the organism can become encysted in cardiac muscle after primary infection. Recipient seronegative status with primary infection after transplant appears to be the most likely mechanism. The donor heart can then become a source of infection for a nonimmune cardiac recipient. Serology should be performed on cardiac donors and recipients to identify patients at risk for disease transmitted by the allograft. The fatality rate is high, and often the diagnosis is not established until autopsy. The treatment of choice is pyrimethamine (50 to 75 mg/day) and sulfadiazine (4 to 6 g/day). Folinic acid (5 to 15 mg/day) is usually added to the regimen to prevent marrow suppression. Nocardiosis may cause single or multiple brain abscesses or, less commonly, meningitis. Nocardia brain abscesses may benefit from stereotactic biopsy and surgical drainage in addition to long-term (9- to 12-month) antimicrobial therapy. Agents such as amikacin, imipenem, and cefotaxime have shown good activity with more rapid killing than sulfonamides. The approach to antiviral prophylaxis and the pretransplantation evaluation of candidates and donors are discussed elsewhere in this book (see Chapter 311). Cumulative incidence curves were censored for patients lost to follow-up; death and retransplantation were considered competing risks. Genital herpes may become clinically evident for the first time after transplantation and can be distressing for the patient. Low-dose acyclovir (400 mg twice daily) for the first 3 to 4 weeks after transplantation is usually sufficient. Antiviral therapy is indicated because healing is often slow and transplant recipients occasionally develop neurologic complications or disseminated infection. Oral therapy with acyclovir, valacyclovir, or famciclovir suffices for dermatomal zoster. If the patient has ophthalmic zoster or there is evidence of dissemination, intravenous acyclovir is used initially. Varicella-seronegative transplant recipients who are exposed may benefit from the use of varicella-zoster immune globulin when given up to 10 days after exposure. Primary infections occurring in seronegative recipients with a seropositive donor are more likely to be symptomatic. The proportion of infected patients who become symptomatic is also a function of the intensity of immunosuppression. The absolute viral load and change in viral load are the most important determinants of symptomatic infection. Abnormalities may be found on liver function tests, although jaundice rarely occurs. Tissue-invasive disease may manifest as pneumonitis, gastrointestinal disease, or hepatitis. The disease is typically mild and may be an incidental finding in asymptomatic patients undergoing liver biopsy to evaluate elevation of their liver enzymes. However, oral valganciclovir is a reasonable alternative in carefully selected non­ severely ill patients, thereby simplifying therapy. The diagnosis is suspected in transplant recipients without a clinical or virologic response, or both, to full-dose ganciclovir therapy and can be confirmed with genotypic resistance testing directly from clinical specimens. Respiratory viral infections received little mention in early reports of infections after organ transplantation but are now recognized to be important pathogens. Adenoviruses are a more common problem after pediatric than adult transplantation. They may cause asymptomatic infection, but they also can cause diffuse pneumonia, necrotizing hepatitis, and hemorrhagic cystitis. Antiviral agents such as ribavirin and cidofovir have been used to treat adenovirus infection, but their effectiveness remains uncertain. The availability of highly sensitive molecular diagnostic tests has significantly improved the ability to make a definitive diagnosis and suggests that transplant patients may have prolonged shedding of these viruses. The overall impact of respiratory viruses appears to be significantly greater in lung compared with other organ transplant recipients. Influenza has been documented frequently in transplant patients in recent studies, particularly among lung transplant recipients.

Lower tract infection has a mortality rate of 80% for respiratory syncytial virus and 30% to 35% for parainfluenza virus blood pressure medication that causes hair loss cheap nifedipine 30 mg buy. Preemptive therapy with aerosolized ribavirin in patients with positive nasopharyngeal cultures for respiratory syncytial virus appears promising pulse pressure vs map order nifedipine in india. Patients who develop respiratory viral pneumonia before engraftment have poorer outcomes arteria facialis linguae generic 20 mg nifedipine with mastercard. Aerosolized ribavirin (Virazole) is administered by a face mask to adults through a small-particle aerosol generator blood pressure bottom number is high purchase nifedipine 30 mg without prescription. Although there are no data on what dose may be effective arteria mesenterica superior purchase generic nifedipine online, 6 g (one vial) per 12 hours once daily is a schedule that has been used. Protection involves the use of frequent hand washing by hospital staff and droplet isolation of patients with colds or respiratory tract symptoms. In addition, family members and health care workers with upper respiratory tract symptoms should be separated from patients. Vaccination of family members, health care workers, and other close contacts against influenza may help control exposures. Amantadine or rimantadine prophylaxis has limited usefulness because of the widespread development of resistance. Responses to antiviral therapy are not universal, and benefits of antiviral therapy have not been rigorously determined. Patients undergoing allogeneic transplantation are at 10-fold increased risk for invasive fungal infection in comparison with patients receiving an autologous graft. Before fluconazole prophylaxis, the onset of candidiasis occurred at a median of 2 to 3 weeks after transplantation and Candida spp. The strategy of prolonged fluconazole therapy has been associated with improved survival rates, although the mechanism of the observed benefits is uncertain. With the use of fluconazole since the 1990s, the number of Candida infections has decreased. Aspergillus and other mold infections are acquired exogenously, by inhalation of spores into the respiratory tract from the environment, and in some localities may occur with higher frequency during the summer. Older age is associated with the acquisition of aspergillosis during either the preengraftment or postengraftment risk periods. The estimated 1-year survival rate among patients with proven invasive aspergillosis is 7% to 30%, although more aggressive, prolonged, or combination antifungal therapies may be improving these outcomes. This extra measure can be implemented on an individual basis: units can be obtained for each of the rooms that the patient will occupy during the day and night, and each unit is sized for the room it will be placed in. There is no evidence of the clinical efficacy of these filters out of the hospital setting in preventing acquisition of airborne mold infections. Other prevention strategies, including nasal and aerosolized amphotericin B, have not been studied in controlled trials. The availability of accurate early diagnostic tests for invasive fungal infections lags behind those for other types of infections. The Aspergil lus galactomannan test is most useful for patients not already taking antifungal therapy that includes coverage for molds, which is a minority of high-risk allogeneic recipients. Blood cultures for molds rarely yield positive findings of mold organisms, except in the case of Fusarium. A high index of suspicion in persistently febrile neutropenic patients and timely computed tomography of the chest to detect new infiltrates are important for early detection of invasive pulmonary aspergillosis. Galactomannan assay of the bronchoalveolar lavage fluid may have augmented diagnostic value. A lack of clinical or radiographic response during empirical antifungal therapy may necessitate tissue sampling. Minimally invasive surgery (video-assisted thoracoscopic surgery) is associated with less morbidity than is open-lung biopsy. Advancedgeneration azole agents and echinocandins have less nephrotoxicity than do lipid preparations of amphotericin B. A lack of clinical or radiographic response during proven infection may necessitate a switch to an agent from a different class or to combination therapy. Combination treatment of fungal infections with echinocandins, azoles, and polyene agents is common, whereas results of a large randomized clinical trial failed to show a benefit. Echinocandin agents may be fungistatic rather than fungicidal in the case of mold infections because their interruption of cell wall synthesis is limited to actively growing hyphae. For documented invasive tissue mold infection, therapy is usually continued until some weeks (4 to 6) after lesions are resolved or stable, immunocompetence has improved, and the patient is afebrile. Although amphotericin B had been the gold standard antifungal agent since the 1960s, voriconazole produced superior outcomes in treatment for aspergillosis in 53% of patients, in contrast to 32% of patients treated with amphotericin B (followed by other antifungal therapy). After initial control of an Aspergillus infection, subsequent maintenance therapy for the duration of immunosuppression has been advocated to reduce the risk for reactivation. Multiple drug-drug interactions occur with the azoles, and adjustments may be required for immunosuppressive agents. Difficulty in achieving therapeutic plasma drug levels complicates the administration of itraconazole and posaconazole. Itraconazole solution has improved oral bioavailability over the capsule and can be used, although blood level monitoring may be needed to ensure adequate absorption. Malassezia furfur causes tinea versicolor, catheter-related fungemia, and sometimes pneumonia. Trichosporonosis has manifested as fungemia, skin lesions, pneumonitis, and arthritis. Widespread antiCandida prophylaxis with fluconazole may contribute to the low frequency of these infections. One postmortem diagnosis of disseminated toxoplasmosis was associated with hemophagocytic syndrome. They are indistinguishable from Aspergillus hyphae in tissue sections; thus, culture is required for identification. Such patients should be revaccinated every 10 years with the combined tetanus-diphtheria-pertussis toxoid, absorbed. Vaccination with acellular pertussis does not generate enough immunity, so vaccines with higher-dose pertussis toxoid should be used until transplant recipients are further studied. If the patient was previously immunized, only one dose of hepatitis B vaccine should be given. Children younger than 9 years who are receiving influenza vaccination for the first time require two doses yearly. Vaccination with the quadrivalent human papillomavirus vaccine has not been studied but may be appropriate for male and female long-term transplant recipients ages 9 to 26 years and perhaps for women older than age 26 who are at risk for squamous intraepithelial lesions. A second measles-mumps-rubella dose should be given 6 to 12 months later; however, the benefit of a second dose in this population has not been evaluated. Routine administration of hepatitis A, meningococcal, and rabies vaccines is not indicated. The major defect in humoral immunity is the absence of specific antibody production. ImmunoglobulinReplacement 3439 KeyReferences the complete reference list is available online at Expert Consult. Higher-risk of cytomegalovirus and Aspergillus infections in recipients of T cell depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immune suppressive therapy to prevent graftversus-host disease. No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Impact of cytomegalovirus reactivation after umbilical cord blood transplantation. Detection of adenoassociated virus viremia in hematopoietic cell transplant recipients. Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Marked increased risk of Epstein-Barr virus­related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. Allogeneic hematopoietic cell transplantation in human immunodeficiency virus­positive patients with hematologic disorders: a report from the Center for International Blood and Marrow Transplant Research. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Fludarabinebased cytoreductive regimen and T-cell­depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Phase 1/2 randomized, placebo-control trial of palifermin to prevent graftversus-host disease after allogeneic hematopoietic stem cell transplantation. Reducedintensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Majorhistocompatibility-complex class I alleles and antigens in hematopoietic cell transplantation. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. The role of different risk factors in clinical presentation of hemorrhagic cystitis in hematopoietic stem cell transplant recipients. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Venoocclusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review. Defibrotide, a polydisperse mixture of single-stranded phosphodiester oligonucleotides with lifesaving activity in severe hepatic venoocclusive disease: clinical outcomes and potential mechanisms of action. Graft-versushost disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Treatment options in steroid-refractory acute graft versus-host disease following hematopoietic stem cell transplantation. Higher-risk of cytomegalovirus and Aspergillus infections in recipients of T cell depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immune suppressive therapy to prevent graft-versus-host disease. A systematic approach to hepatic complications in hematopoietic stem cell transplantation. Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon. Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Infectious gastroenteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantation. Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on procedure-related mortality. Epidemiology of bacteremia and factors associated with multidrug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study.

Order genuine nifedipine on-line. How to Use Wrist Blood Pressure Monitor.

References

• Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009;53:1475-1487.
• Morton RA, Ewing CM, Nagafuchi A, et al: Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells, Cancer Res 53:3585n3590, 1993.
• Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
• Milgram JW. Morphologic alterations of the subchondral bone in advanced degenerative arthritis. Clin Orthop Relat Res 1983; 173:293-312.